Skip to main content
. 2022 Nov 18;39(1):51–58. doi: 10.1177/08903344221134631

Table 4.

Comparisons of the Levels of Anti-RBD-Specific IgA and IgG in Participants’ Milk Following the Vaccine Booster (N = 12).

Time (Day) IgA Analysis
IgG Analysis
Group Comparison
Mdn UL, LL p Mdn UL, LL p p
-30 -0.954 36.28, -10.08 0.9926 6.281 12.85, 4.16 >0.9999 0.0394
-1 -2.433 20.74, -10.32 - 5.548 9.46, 2.68 - 0.0004
7 9.069 55.74, -1.32 <0.0001 9.058 143.02, 4.56 0.0380 >0.9999
14 -1.600 49.36, -7.00 0.9659 22.945 294.35, 3.15 <0.0001 <0.0001
21 -1.117 41.03, -11.02 0.3060 15.461 294.35, 3.93 <0.0001 <0.0001
30 -1.471 18.48, -8.80 0.7981 14.419 235.67, 3.83 <0.0001 <0.0001
45 0.795 26.91, -7.60 0.0479 12.801 296.85, 3.07 0.0003 <0.0001
60 7.915 32.81, -7.44 <0.0001 28.243 294.35, 3.31 <0.0001 0.0252

Note. Median IgA and IgG levels are reported in units/ml (U/ml). Negative values indicate that the standardized sample value was lower than the negative control milk value. The p values reported within each IgA and IgG analysis column were determined via a Dunn’s multiple comparisons test where the dataset from each time was compared to the dataset from Day -1. The p values reported in the last column are from a Dunn’s multiple comparisons test evaluating differences between IgA and IgG levels at each time point. Missing values: Day -30 = 4, Day -1 = 2, Day 7 = 5 for the IgA analysis and 3 for the IgG analysis, Day 14 = 2, Day 21 = 3, Day 30 = 1, and Day 45 = 1. IgA = Immunoglobulin A; IgG = Immunoglobulin G; Mdn = median; UL = upper limit; LL = lower limit.